CDC: Prevalence of Arthritis 31.8% in Most Rural Areas of U.S.

Share this content:
CDC: Prevalence of Arthritis 31.8% in Most Rural Areas of U.S.
CDC: Prevalence of Arthritis 31.8% in Most Rural Areas of U.S.

WEDNESDAY, May 31, 2017 (HealthDay News) -- The prevalence of arthritis is 31.8 percent in the most rural areas and 20.5 percent in the most urban areas of the United States, according to research published in the May 26 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Michael A. Boring, from the CDC in Atlanta, and colleagues examined the prevalence of arthritis and arthritis-attributable activity limitation (AAAL) across urban-rural areas overall and among selected subgroups. Data were analyzed from the 2015 Behavioral Risk Factor Surveillance System.

The researchers found that in the most rural areas, the unadjusted prevalence of arthritis was 31.8 percent, compared with 20.5 percent in the most urban areas. Among adults with arthritis, the unadjusted AAAL prevalence was 55.3 and 49.7 percent in the most rural and most urban areas, respectively.

"Approximately one in three adults in the most rural areas have arthritis and over half of these adults have AAAL," the authors write. "Wider use of evidence-based interventions, including physical activity and self-management education, in rural areas might help reduce the impact of arthritis and AAAL."

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths